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The cocarcinogenic effect of intrarectal deoxycholate in rats
is reduced by oral metronidazole
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Summary Bile acids enhance colorectal carcinogenesis in animals and man, perhaps after degradation by
faecal anaerobes. The promotional effect of sodium deoxycholate (SDC) and its relationship to bacteria was
examined in male Sprague-Dawley rats (n = 115) which had received a 6-week course of azoxymethane (total
dose 90mgkg 1 s.c.) Two groups received 3 x weekly intrarectal (i.r.) instillations of N saline or 0.12M SDC
for 18 weeks. Another group received SDC i.r. plus metronidazole (22.5mgkg-1) daily in the drinking water.
Controls had no instillations or metronidazole alone. By 28 weeks SDC had increased mean colonic crypt
depth by 9% (P<0.001), and had almost trebled colorectal tumour yields from 2.4+0.4 per rat (mean + s.e.)
in controls to 6.4+0.5 (P<0.001). Tumour yields after SDC + metronidazole (4.2+0.5) remained 75%
higher than in controls (P<0.01) but were 33% less than after SDC alone (P<0.01), and the increase in
crypt depth was maintained at 7% (P<0.001). Neither metronidazole alone nor saline i.r. had any effect on
tumour yield, but metronidazole alone reduced crypt depth by 9% (P<0.001). Deoxycholate is a potent
cocarcinogen and also stimulates mucosal hyperplasia. Metronidazole reduces its tumour-promoting effect,
suggesting that faecal anaerobes are important in bile acid cocarcinogenesis.
Bile acids are strong candidates for the role of
endogenous promoters of colorectal cancer (Reddy,
1981; Thompson, 1982). They bear a close steric
resemblance to an established group of carcinogens,
the polycyclic aromatic hydrocarbons. Human gut
flora can cause partial aromatization of the steroid
ring, and full conversion to 3-methylcholanthrene
might be achieved by a series of chemical reactions
(Hill, 1971). Faecal excretion of bile acids is greater
in populations from high-risk countries (Western
Europe, USA) as opposed to low-risk countries
(Asia, Africa), and in meat eaters as opposed to
vegetarians (Reddy & Wynder, 1973; Hill et al.,
1971; Aries et al., 1969). Deoxycholic acid receptors
have been identified in human colorectal cancers
(Summerton et al., 1982).
In theory, bile acids and their metabolites could
either exert a direct mutagenic effect on the
epithelial cell or act indirectly by altering the rate
of mucosal cell proliferation and hence
susceptibility to carcinogenesis. In the rat diversion
of pancreaticobiliary secretions to mid small bowel
enhances colorectal carcinogenesis (Chomchai et al.,
1974; Williamson et al., 1979) and also stimulates
marked adaptive hyperplasia of the ileum and
moderate colonic hyperplasia (Williamson et al.,
1978). However, bile acids appear to be neither
tropic nor cocarcinogenic to hypoplastic
defunctioned colon (Rainey et al., 1983). The
composition of the colonic microbial flora is
implicated as the key intermediary modulating the
effect of luminal bile acids (Aries et al., 1969; Hill,
1979). Anaerobes, in particular, may metabolise bile
acids to yield products which are carcinogenic or
cocarcinogenic. (Hill, 1974).
This experiment was designed to test the tropic
and cocarcinogenic potential of sodium deoxy-
cholate instilled directly into the large bowel of rats
exposed to azoxymethane. In addition we examined
the effect of oral metronidazole, an anaerobicide, in
modifying this potential.
Materials and methods
Experimental animals
One hundred and fifteen male Sprague-Dawley rats
(Olac SD, Bicester, Oxon) weighing 70-100g were
received into the animal house 1 week before the
start of the experiment and were allocated to one of
five groups (Figure 1). They were fed standard rat
chow (Oxoid Breeding Diet; H C Styles & Co Ltd.,
Bewdley, Worcs) and water ad libitum. Animal
quarters were lit in alternate 12-hourly cycles. Rats
were weighed weekly throughout the experiment.
All animals received weekly s.c. injections of azoxy-
methane (Ash Stevens Inc., Detroit, Michigan,
USA) 15 mgkg 1 for 6 weeks (Figure 1).
One week after the last injection of azoxy-
methane intrarectal (i.r.) instillations were carried
out for the first time in groups 3-5. Colonic
washout was not carried out and anaesthesia was
unnecessary. An 18-gauge plastic i.v. cannula was
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Figure 1 Experimental design. SDC = sodium deoxycholate. Numbers in each group at the start of the
experiment and surviving until sacrifice are shown.
inserted through the anus to a distance of 5 cm in
rats suitably restrained by an experienced handler.
Rats in group 3 received 1 ml N saline. Groups 4
and 5 received 1 ml of 0.12 M sodium deoxycholate
(SDC) prepared by dissolving 50 g SDC (Sigma
Chemical Co., St Louis, USA) in 1 litre N saline;
each 1 ml aliquot contained 0.05 g (120 pmol) of
SDC. Instillations were carried out 3 times per
week for 18 weeks (Figure 1).
In addition, rats in group 5 received metroni-
dazole (22.5mgkg-1 rat day-1; May & Baker Ltd.,
Dagenham, Essex) dissolved in the drinking water
from the start of the instillations until the end of
the experiment. Group 1 rats (controls) received
neither i.r. instillations nor metronidazole, and
those in group 2 received metronidazole alone
(Figure 1).
Autopsy specimens
Rats were regularly examined for evidence of
tumour development and were killed when
moribund or at the end of 28 weeks. At autopsy
the entire intestinal tract was excised. The following
segments were thoroughly flushed with cold saline
to remove all content: duodenum, jejunoileum and
colorectum. The length of each segment was
determined by suspension with a constant weight
against a ruler. Segments were then opened, and the
number, size and position of all tumours were
recorded. After excision of the tumours the
remaining bowel was blotted dry and weighed. The
net weights of the caecum, liver, kidneys and spleen
were also recorded. All tumours were fixed in 10%
formalin before histological processing.
Subsequently 5 pm sections were prepared for
staining with haematoxylin and eosin.
In addition, a 1 cm specimen of colon was excised
5-6 cm from the anus, and similar histological
specimens were prepared. The mean crypt depth
was estimated by ocular micrometry of 10 perfectly-
sectioned crypts per slide.
Statistics
Student's t-test was used for statistical analysis of
the data.
Results
Mortality rate
Eleven rats (10%) died before sacrifice either from
colonic perforation during instillation (2 rats),
haemorrhage secondary to duodenal or colonic
cancer (2), haematuria (1), pneumonia (2), or
cancer of the external auditory canal (1). In 3 rats
that died during the early part of the experiment,
the cause of death could not be determined. The
yields of surviving animals at the end of the
experiment are given in Figure 1.
Body weight
Rats in all groups gained weight steadily until week
25, after which weights remained constant until
sacrifice 3 weeks later. Neither i.r. deoxycholate nor
oral metronidazole had any consistent effect on
body wt.
Intestinal adaptation
No differences between the groups were found in
the lengths and weights of the duodenum, jejuno-
ileum or colorectum, nor in the weights of the
caecum, liver, kidneys or spleen.
The mean colonic crypt depth in controls was
226+33m (mean + s.e.) compared with 246+3,um
in the SDC-irrigated group and 242 +3pm in the
SDC+metronidazole group (P<0.001; Figure 2).
Intrarectal saline had no effect on 'crypt depth
compared with controls, but metronidazole alone
produced a 9% decrease (211 ±3 pm: P<0.001).
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Figure 2 Colonic crypt depth at sacrifice (28 weeks).
SDC =sodium deoxycholate.
Intestinal tumours
All but 2-3 rats in each group developed one or
more colorectal tumours (Figure 3). Intrarectal
deoxycholate almost trebled colorectal tumour
yields from 2.4+0.4 per rat (mean + s.e.) in controls
to 6.4+0.5 (P<0.001). Metronidazole reduced this
effect by 33% (P<0.01), but the tumour yield
(4.2+0.5) remained 75% higher than that in
controls (P<0.01). Neither metronidazole alone
(2.2+0.6 tumours per rat) nor i.r. saline (2.8+0.5)
had any effect on colorectal carcinogenesis. No
significant differences in tumour size were found
between groups.
The overall pattern of colorectal tumour
distribution was similar in the 5 groups. Ninety-six
percent of all tumours developed in the distal 60%
of the large bowel (Figure 4). The effect of SDC
instillation was maximal in the distal 40% segment,
where it produced a 193% increase in tumour yield
over controls (P<0.01), while the increase proximal
to this was only 14%. Clearly the instillations were
effectively reaching this distal 40% segment.
Tumours also arose in the duodenum (n=5) and
jejunum (3), but their incidence was unaffected by
SDC or metronidazole administration. In addition,
3 rats developed tumours of the external auditory
canal, and metastases were found in the lung, liver
and omentum.
** P vs 1 2 3 <0.001
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Figure 3 Colorectal tumour yields. SDC=sodium
deoxycholate.
Histological types of benign and malignant
neoplasms were as previously described (Williamson
et al., 1979; Rainey et al., 1983).
Discussion
The data support the contention that sodium
deoxycholate is a potent promoter of experimental
colorectal carcinogenesis. Oral administration of
primary bile acids has increased tumour yields in
various models: rats and mice given dimethyl-
hydrazine (Martin et al., 1981) or methylnitro-
sourea (Cohen et al., 1980), and rats with
'spontaneous' cancers arising at a colostomy (Sauer
et al., 1980). Direct exposure of colorectal mucosa
to primary or secondary bile acid solutions instilled
per rectum also promotes carcinogenesis in response
to the contact carcinogen N-methyl-N'-nitro-N-
nitroso-guanidine (Narisawa et al., 1974; Reddy et
al., 1977). These experimental data are supported
by a wealth of epidemiological surveys identifying
bile acids as major cocarcinogens (Reddy, 1981;
Thompson, 1982).
The mechanism of action of bile acids in colonic
carcinogenesis has not been elucidated. They might
directly damage the epithelial cell: lithocholic acid
can induce DNA strand breaks in cultured cells
(Kulkarni et al., 1982). Bile acids are tropic to ileal
mucosa (Williamson et al., 1978), and our finding
that SDC increases colonic crypt depth indicates
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Figure 4 Colorectal tumour distribution. SDC=sodium deoxycholate. Estimated distance of i.r. cannula
insertion is shown.
that they produce a similar response in colonic
mucosa. Hyperplasia is a strong promoter of
experimental intestinal cancer (Williamson 1982a;
Barthold, 1981). Both varying degrees of small
bowel resection and pancreaticobiliary diversion to
mid small bowel result in moderate colonic hyper-
plasia and the enhancement of colorectal carcino-
genesis (Williamson, 1982a). The tropic effects of
SDC on colonic mucosa might therefore be
sufficient to explain its tumour-promoting effect.
Possibly bile acids produce hyperplasia by causing
chronic irritation and inflammation of the mucosa,
rendering it more susceptible to carcinogenesis.
Certainly, the chronic inflammation of ulcerative
colitis in man increases the risk of colorectal cancer
(Lennard-Jones et al., 1977; van Heerden & Beart,
1980). We have recently found that isolating a long
segment of colon from the faecal stream as a Thiry-
Vella fistula produces both mucosal hypoplasia and
reduced susceptibility to azoxymethane (Rainey et
al., 1983). SDC instillation into this defunctioned
colon has no effect on the reduced tumour yield or
the mucosal hypoplasia. Clearly SDC requires the
presence of faeces or some faecal constituent in
order to exert its cocarcinogenic effects. Absent in
defunctioned bowel, the mechanical stimulus of
faecal bulk may be important in maintaining
normal mucosal cell turnover (Williamson, 1982b).
Similarly a normal bacterial flora is necessary for
maintenance of the normal mucosal proliferative
state (Abrams et al., 1962), and its composition may
modulate carcinogenesis (Hill, 1979). The bacterial
population in a defunctioned Thiry-Vella fistula is
probably very different both qualitatively and
quantitatively from that in normal functioning
colon.
In this study, metronidazole had no effect on
carcinogenesis in response to azoxymethane alone.
Yet Goldin & Gorbach (1981) have found that the
administration of tetracycline or erythromycin to
rats receiving dimethylhydrazine markedly reduces
colorectal carcinogenesis; these antibiotics have a
different spectrum of antibacterial activity than
metronidazole. Since chemical carcinogenesis is also
reduced in germ-free rats (Reddy et al., 1975a), it is
possible that the dose of metronidazole did not
reduce the population and metabolic activity of
colonic bacteria enough to inhibit carcinogenesis.
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Nevertheless there was a slight but significant
reduction in colonic crypt depth, similar to that
found in the ileum of germ-free mice (Abrams et
al., 1962).
The importance of faecal anaerobes in the
cocarcinogenic role of bile acids is highlighted by
the finding that metronidazole partly suppresses the
effect of intrarectal SDC. Nuclear-dehydro-
generating clostridia in particular are capable of
producing unsaturated steroids from the bile acid
nucleus (Hill, 1974). These organisms may be more
numerous in the faeces of patients with colorectal
cancer than in control groups (Hill, 1975; Murray
et al., 1980). In man, high fat/low protein diets
increase the total anaerobic microfloral content of
the faeces as well as the activity of the bacterial
enzyme beta-glucuronidase (Reddy & Wynder,
1973; Reddy et al., 1975b; Goldin & Gorbach,
1976). The concentration of faecal anaerobes in one
high-risk population (British) exceeded that of a
low-risk population (Ugandan) especially for those
bacteria capable of degrading bile acids (Hill et al.,
1971; Aries et al., 1969). Other studies have found
no difference in bacterial populations between
groups at varying risk (Moore & Holdeman, 1975;
Finegold et al., 1975), so that the metabolic activity
of the microbial flora may be more relevant than
the actual numbers of individual species (Reddy et
al., 1980). Since bile acids remain cocarcinogenic in
germ-free rats, the presence of bacteria is clearly
not essential (Reddy et al., 1977). Similarly in this
experiment, although metronidazole reduced the
promotional effect of intrarectal SDC, deoxycholate
remained strongly cocarcinogenic.
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